Prof. Zhou studied medicine at Nantong Medical College and got Master of Medicine at Bengbu Medical College and the Ph.D at China Medical University in China. He worked at Affiliated Hospital of Bengbu Medical College up to 1998. In 1998, Prof Zhou moved to Shanghai and got a position as professor and director in the Department of Medical Oncology at Shanghai Pulmonary Hospital, Tongji University. He has more than 30 years of experience in clinical oncology with his main research interests focusing on early detection, molecular targeted therapy, and immunotherapy in lung cancer. He have lead or been involved in many multicenter clinical studies, including OPTIMAL, ALESIA, BEYOND, CAMEL, RATIONAL 303, CAEML-sq, etc.

Prof Zhou has published over 200 articles in the peer-review journals, including the Lancet Oncology, Lancet Respiratory Medicine and Journal of Clinical Oncology.
He is also involved in several professional societies, including BOD of IASLC, associate editor of IASLC Newsletter, chairmen of the NSCLC expert society in Chinese Society of Clinical Oncology (CSCO) and chairman of Thoracic Oncology Society in CPAM.
In addition, he is the Editor-in-Chief of the Translation Lung Cancer Research, the Associate Editor of the Lung Cancer and serves on the Editorial Board of several other major oncology journals.